Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Statistics

Total Valuation

CLDX has a market cap or net worth of $1.24 billion. The enterprise value is $614.20 million.

Market Cap	1.24B
Enterprise Value	614.20M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CLDX has 66.39 million shares outstanding. The number of shares has increased by 29.03% in one year.

Current Share Class	66.39M
Shares Outstanding	66.39M
Shares Change (YoY)	+29.03%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	0.28%
Owned by Institutions (%)	98.03%
Float	56.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	173.42
Forward PS	514.94
PB Ratio	1.87
P/TBV Ratio	1.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	81.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.67, with a Debt / Equity ratio of 0.00.

Current Ratio	21.67
Quick Ratio	21.06
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -23.20% and return on invested capital (ROIC) is -17.55%.

Return on Equity (ROE)	-23.20%
Return on Assets (ROA)	-16.88%
Return on Invested Capital (ROIC)	-17.55%
Return on Capital Employed (ROCE)	-30.70%
Revenue Per Employee	$40,640
Profits Per Employee	-$961,565
Employee Count	186
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.75% in the last 52 weeks. The beta is 1.39, so CLDX's price volatility has been higher than the market average.

Beta (5Y)	1.39
52-Week Price Change	-46.75%
50-Day Moving Average	19.10
200-Day Moving Average	26.11
Relative Strength Index (RSI)	49.43
Average Volume (20 Days)	759,549

Short Selling Information

The latest short interest is 9.13 million, so 13.75% of the outstanding shares have been sold short.

Short Interest	9.13M
Short Previous Month	9.01M
Short % of Shares Out	13.75%
Short % of Float	16.19%
Short Ratio (days to cover)	10.53

Income Statement

In the last 12 months, CLDX had revenue of $7.56 million and -$178.85 million in losses. Loss per share was -$2.70.

Revenue	7.56M
Gross Profit	-176.94M
Operating Income	-217.21M
Pretax Income	-150.22M
Net Income	-178.85M
EBITDA	-213.94M
EBIT	-217.21M
Loss Per Share	-$2.70

Balance Sheet

The company has $673.29 million in cash and $3.43 million in debt, giving a net cash position of $669.86 million or $10.09 per share.

Cash & Cash Equivalents	673.29M
Total Debt	3.43M
Net Cash	669.86M
Net Cash Per Share	$10.09
Equity (Book Value)	702.98M
Book Value Per Share	10.59
Working Capital	661.74M

Cash Flow

In the last 12 months, operating cash flow was -$171.51 million and capital expenditures -$1.84 million, giving a free cash flow of -$173.35 million.

Operating Cash Flow	-171.51M
Capital Expenditures	-1.84M
Free Cash Flow	-173.35M
FCF Per Share	-$2.61

Margins

Gross Margin	n/a
Operating Margin	-2,873.52%
Pretax Margin	-2,366.07%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.03%
Shareholder Yield	-29.03%
Earnings Yield	-13.93%
FCF Yield	-13.50%

Analyst Forecast

The average price target for CLDX is $50.00, which is 167.95% higher than the current price. The consensus rating is "Buy".

Price Target	$50.00
Price Target Difference	167.95%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	155.13%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on February 11, 2019. It was a reverse split with a ratio of 0.0666666:1.

Last Split Date	Feb 11, 2019
Split Type	Reverse
Split Ratio	0.0666666:1

Scores

CLDX has an Altman Z-Score of 31.21 and a Piotroski F-Score of 1.

Altman Z-Score	31.21
Piotroski F-Score	1